Company Filing History:
Years Active: 2014-2015
Title: Innovations by Inventor Ching-Yun Li
Introduction
Ching-Yun Li is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of radiotracers and pharmaceutical compositions, particularly in the context of liver cancer treatment. With a total of 2 patents, his work showcases the intersection of chemistry and medical imaging.
Latest Patents
Ching-Yun Li's latest patents include a precursor used for labeling hepatocyte receptors, which contains a trisaccharide and diamide dimercaptide ligand. This innovative precursor is designed for use in radiotracers aimed at imaging or treating liver cancers. The bifunctional compound features a trisaccharide structure that exhibits a high affinity for asialoglycoprotein receptors on hepatocyte surfaces. The diamide dimercaptide ligand interacts with radioisotopes to form neutral complexes, allowing for effective radioisotope labeling and treatment of liver cancers.
Another significant patent involves a precursor SnBZM for a dopamine receptor radiotracer. This precursor includes a tributyltin group that is easily replaceable, enabling the production of the dopamine receptor radiotracer I-IBZM at a high yield rate through a substitution reaction. The methods for preparing both the precursor SnBZM and a reference standard IBZM have been simplified, enhancing the stability of the resulting products.
Career Highlights
Ching-Yun Li is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he continues to advance research in nuclear medicine and radiopharmaceuticals. His work is pivotal in developing new methods for imaging and treating diseases, particularly in the realm of oncology.
Collaborations
Ching-Yun Li collaborates with esteemed colleagues, including Show-Wen Liu and Yu Lung Chang. Their combined expertise fosters innovation and enhances the research output in their respective fields.
Conclusion
Ching-Yun Li's contributions to the field of radiotracers and pharmaceutical compositions are noteworthy. His innovative patents reflect a commitment to improving medical imaging and treatment options for liver cancer. Through his work, he continues to make a significant impact in the realm of nuclear medicine.